Skip to content

A prospective randomized controlled study of direct anterior approach (DAA) versus conventional posterolateral approach (PLA) total hip arthroplasty for the injury of hip joint proprioception and the establishment of accessible evaluation system

A prospective randomized controlled study of direct anterior approach (DAA) versus conventional posterolateral approach (PLA) total hip arthroplasty for the injury of hip joint proprioception and the establishment of accessible evaluation system

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058487
Enrollment
Unknown
Registered
2022-04-09
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

joint proprioception after hip replacement

Interventions

Group 1:Conventional posterolateral approach for hip arthroplasty
Group 2:Minimally invasive direct anterior approach for hip replacement

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Suffering from hip osteoarthritis, aseptic necrosis of the femoral head, hip dysplasia and femoral neck fracture; 2. Clinical symptoms, physical examination and imaging examination all confirm the need for artificial hip replacement; 3. BMI index < 30 kg/m2; 4. No general anesthesia and surgical contraindications; 5. Sign the informed consent; 6. Patients themselves can communicate effectively, agree to artificial joint replacement surgery, have good compliance, and can conduct follow-up visits and examinations on time.

Exclusion criteria

Exclusion criteria: 1. Those who are in poor general condition and have serious underlying diseases of important organs and cannot tolerate general anesthesia or surgery; 2. The surgical site is suffering from an infectious disease or there is a sinus tract in the local skin; 3. Crow type IV hip dysplasia, fused hip, and rigid hip; 4. Those who have undergone ipsilateral hip replacement surgery and need revision; 5. Elderly patients, aged greater than or equal to 80 years old; pregnant and lactating women; 6. Unable to cooperate with follow-up visits.

Design outcomes

Primary

MeasureTime frame
Harris hip score;

Secondary

MeasureTime frame
C-reactive protein;Joint Position Sense;Creatine kinase;interleukin-6;Tumor necrosis factor-a;

Countries

China

Contacts

Public ContactMa Jinzhong

Shanghai General Hospital

majinzhong1963@sina.com+86 13386259521

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026